Program

DAY3Friday, November 15

Please click each presentation title to see the abstract.

Session 9: Tumor Diversity, Susceptibility and Resistance I
Chair: Yasuyuki Fujita, Kyoto University
9:00-9:40
Somatic mosaicism and cancer
Seishi Ogawa (Kyoto University)
9:40-10:20
Towards therapies that are designed to exploit biological cancer vulnerabilities
Hans Guido Wendel (Memorial Sloan Kettering Cancer Center)
10:20-10:35
Break
Session 10: Tumor Diversity, Susceptibility and Resistance II
Chair: Seishi Ogawa, Kyoto University
10:35-11:15
The dirty secrets of cancer immunology: links between gut microbiota and tumor immunosurveillance
Laurence Zitvogel (Gustave Roussy Institute)
11:15-11:55
Understanding of GI cancer initiation and progression using organoids
Toshiro Sato (Keio University)
11:55-12:15
Short talk
Clonal evolution from normal cells to cancer
Nobuyuki Kakiuchi (Kyoto University)
12:15-12:35
Short talk
Immune cell with somatic mutations regulate tumor microenvironments
Mamiko Sakata-Yanagimoto (University of Tsukuba)
12:35-
Closing Remarks